A 6-year safety surveillance of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in South Korea

A 6-year safety surveillance of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in South Korea

In 2010, Korea introduced 10-valent pneumococcal conjugate vaccine for children aged 6 weeks to 5 years against invasive disease caused by Streptococcus pneumoniae serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, 23F and cross-reactive 19A. The aim of this 6-year real-world study of 646 healthy Korean c...

Full description

Bibliographic Details
Main Authors: Soon Min Lee, Jang Hoon Lee, Eun Song Song, Sung Jin Kim, Joon Hyung Kim, Rupert W. Jakes, Raghavendra Devadiga, Moon Sung Park
Format: Article
Language:English
Published: Taylor & Francis Group 2018-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
10-valent pneumococcal conjugate vaccine
phid-cv
safety
korea
Online Access:http://dx.doi.org/10.1080/21645515.2018.1502525

Internet

http://dx.doi.org/10.1080/21645515.2018.1502525

Similar Items